We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

71 hedge funds and large institutions have $120M invested in VanEck Biotech ETF in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $6.29M | Put options by funds: $3.83M

1.88% less ownership

Funds ownership: 24.14% → 22.25% (-1.9%)

21% less funds holding

Funds holding: 90 → 71 (-19)

28% less capital invested

Capital invested by funds: $167M → $120M (-$47.4M)

43% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 30

68% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 25

Holders
71
Holders Change
-19
Holders Change %
-21.11%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
30
Closed
25
Calls
$6.29M
Puts
$3.83M
Net Calls
+$2.46M
Net Calls Change
+$2.55M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$4.42M
2
VF
Virtu Financial
New York
+$2.81M
3
AL
Aspiriant LLC
California
+$2.66M
4
SG Americas Securities
SG Americas Securities
New York
+$2.25M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$980K

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$8.85M
2
LTFS
Ladenburg Thalmann Financial Services
Florida
-$2.19M
3
UBS Group
UBS Group
Switzerland
-$1.69M
4
Wells Fargo
Wells Fargo
California
-$1.44M
5
BPC
Banque Pictet & Cie
Switzerland
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
76
HighTower Advisors
Illinois
– -$627K -4,945 Closed
CWM
77
Concert Wealth Management
California
– -$623K -4,920 Closed
CFMC
78
Curbstone Financial Management Corp
New Hampshire
– -$438K -3,450 Closed
ICAS
79
Investors Capital Advisory Services
Massachusetts
– -$323K -2,545 Closed
PTC
80
Private Trust Company
Ohio
– -$318K -2,511 Closed
DBIA
81
Dumont & Blake Investment Advisors
New Jersey
– -$289K -2,275 Closed
Brown Advisory
82
Brown Advisory
Maryland
– -$258K -2,030 Closed
SBIA
83
Sheaff Brock Investment Advisors
Indiana
– -$241K -1,900 Closed
CB
84
Commerce Bank
Missouri
– -$209K -1,650 Closed
CA
85
Commerzbank Aktiengesellschaft
Germany
– -$208K -1,640 Closed
AFP
86
Ausdal Financial Partners
Iowa
– -$127K -1,003 Closed
CG
87
Colony Group
Massachusetts
– -$74K -580 Closed
BFEC
88
Benjamin F. Edwards & Company
Missouri
– -$48K -375 Closed
KPCM
89
Kings Point Capital Management
New York
– -$34K -270 Closed
OFS
90
Orrstown Financial Services
Pennsylvania
– -$13K -100 Closed
SJIM
91
St. Johns Investment Management
Florida
– -$13K -100 Closed
WA
92
WFG Advisors
Texas
– -$13K -100 Closed
PIM
93
Parasol Investment Management
Illinois
– -$10K -75 Closed
AIA
94
Allegis Investment Advisors
Idaho
– -$1K -10 Closed
ACM
95
Argentus Capital Management
Texas
– -$1K -5 Closed
1 2 3
4

BBH Hedge Fund Activity: Q1 2016 in Review

71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2016, worth a combined $120M — down 28% from $167M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BBH and 8 opened new positions — a net loss of 17 holders — while 30 trimmed existing stakes and 17 added.

The largest buyer was Morgan Stanley, adding an estimated $4.42M. The largest seller was Credit Suisse, exiting entirely with an estimated $8.85M sold.

  • 71 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2016, down from 90 in Q4 2015.
  • Funds reported $120M of VanEck Biotech ETF stock for Q1 2016, down 28% quarter-over-quarter.
  • 8 funds opened new VanEck Biotech ETF positions in Q1 2016 and 25 closed out, a net change of -17 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2016 was Morgan Stanley, an estimated $4.42M added.
  • The largest VanEck Biotech ETF seller in Q1 2016 was Credit Suisse, an estimated $8.85M sold.

Based on aggregated 13F filings for Q1 2016.